Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial

Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial

Background: Artemisia annua is the most common outdoor aeroallergen throughout Northern China; however, no multicenter study has investigated sublingual immunotherapy (SLIT) as a treatment option for Artemisia annua-induced allergic rhinitis (AR). The aim of this study was to evaluate the efficacy a...

Full description

Bibliographic Details
Main Authors: Hongfei Lou, Xueyan Wang, Qingyu Wei, Changqing Zhao, Zhimin Xing, Qinna Zhang, Juan Meng, Shaoqiang Zhang, Huifang Zhou, Ruixia Ma, Hua Zhang, Hui Liu, Weiguo Xue, Chengshuo Wang, Luo Zhang
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:World Allergy Organization Journal
Subjects:
Sublingual immunotherapy
Allergic rhinitis
Artemisia annua
Efficacy
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455120303616

Internet

http://www.sciencedirect.com/science/article/pii/S1939455120303616

Similar Items